In a rat model of inflammatory anemia, roxadustat corrected anemia by reducing hepcidin expression in the liver and increasing the expression of two genes involved in intestinal iron absorption (DcytB and DMT1) [48]. The gene discussed is HAMP; the disease is anemia (phenotype).